Prot #AFT-46: CHIO3 Trial: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date4/21/214/21/24

Funding

  • Alliance Foundation Trials, LLC (Prot #AFT-46)
  • AstraZeneca Pharmaceuticals LP (Prot #AFT-46)